Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016

Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016

Summary

GlobalData’s “Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016” report is an essential source of information and analysis on the global Drug Eluting Stents (DES) market. The report identifies the key trends shaping and driving the dynamism in the global Drug Eluting Stents (DES) market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global Drug Eluting Stents (DES) sector.

Scope

- Annualized global Drug Eluting Stents (DES) market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated company shares data for 2008.
- Analysis and review of the key events and milestones that will impact the future of the global Drug Eluting Stents (DES) market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
- Insightful review of key industry drivers, restraints and challenges which are likely to impact the global Drug Eluting Stents (DES) market in the long run.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies. Key companies include Cordis Corporation, - Boston Scientific, Medtronic, and Abbott Laboratories.
- Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global Drug Eluting Stents (DES) market.
- Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global Drug Eluting Stents (DES) market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- Support your go/non-go dilemma by identifying the markets that are least competitive and present significant opportunities for innovation and growth.
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

1 Table Of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Executive Summary 8
3 Global DES Market : Market Characterization 9
3.1 Overview 9
3.2 DES, Revenue ($ m), Global, 2002 – 2009 9
3.3 DES, Revenue ($ m), Global, 2009 – 2016 10
3.4 DES: Market Dynamics 11
3.4.1 Market Drivers 11
3.4.1.1 Increasing Prevalence of Coronary Artery Disease to Drive DES Market 11
3.4.1.2 Rise in Obesity and Increasing Aging Population Worldwide to Advance the Market 12
3.4.1.3 Innovation to Drive the Market 12
3.4.1.4 Reduction in Re-Interventions in Diabetics- A Population Highly Susceptible To Restenosis to Boost Sales 14
3.4.1.5 High Reimbursement Coverage to Boost Adoption 14
3.4.1.6 Minimally Invasive Surgery to Play Vital Role in Market Development 14
3.4.2 Market Restraints 15
3.4.2.1 High Cost of DES to Hamper the Market Growth 15
3.4.2.2 Side effects like Late-stent Thrombosis and Requirement of Prolonged Dual Anti-platelet Therapy with DES Use to Affect Market Expansion 15
3.4.2.3 Negative Publicity Related to Stent Market Have Affected the Usage of DES 15
3.4.2.4 Alternative Treatment Options Creating a Threat to the Usage of Coronary Stents 15
3.5 DES: Perception Analysis 16
3.6 DES: Opportunities and Unmet Need 17
3.7 Key Takeaway 19
4 Global DES Market : Competitive Assessment 20
4.1 Overview 20
4.2 Strategic Competitive Assessment 20
4.3 Company Shares 2009 22
4.3.1 Cordis Corporation (Johnson & Johnson) 23
4.3.2 Boston Scientific 23
4.3.3 Medtronic 23
4.3.4 Abbott Laboratories 23
4.3.5 Others 23
4.4 Product Profiles of the Major Marketed Products in the DES Market 24
4.4.1 Cypher 24
4.4.1.1 Overview 24
4.4.1.2 Efficacy 24
4.4.1.3 Safety Profile 24
4.4.1.4 Pricing 24
4.4.1.5 Clinical Study Details 24
4.4.2 Taxus 27
4.4.2.1 Overview 27
4.4.2.2 Efficacy 27
4.4.2.3 Safety 27
4.4.2.4 Pricing 27
4.4.2.5 Clinical Study Details 27
4.4.3 Endeavor 29
4.4.3.1 Overview 29
4.4.3.2 Efficacy 29
4.4.3.3 Safety Profile 29
4.4.3.4 Pricing 29
4.4.3.5 Clinical Study Details 29
4.4.4 Xience/Promus 31
4.4.4.1 Overview 31
4.4.4.2 Efficacy 31
4.4.4.3 Safety Profile 31
4.4.4.4 Pricing 31
4.4.4.5 Clinical Study Details 32
4.5 Key Takeaway 35
5 Global DES Market: Pipeline Assessment 36
5.1 Overview 36
5.2 Strategic Pipeline Assessment 36
5.3 DES – Pipeline by Clinical Phase of Development 39
5.4 Profiles of Promising Devices in Clinical Development 40
5.4.1 Endeavor Resolute 40
5.4.1.1 Overview 40
5.4.1.2 Efficacy 40
5.4.1.3 Safety 40
5.4.1.4 Clinical Study Details 41
5.4.2 VESTAsync 43
5.4.2.1 Overview 43
5.4.2.2 Efficacy 43
5.4.2.3 Safety 43
5.4.2.4 Clinical Study Details 43
5.4.3 Nobori Stent 44
5.4.3.1 Overview 44
5.4.3.2 Efficacy 44
5.4.3.3 Safety 44
5.4.3.4 Clinical Study Details 45
5.4.4 XIENCE NANO 45
5.4.4.1 Overview 45
5.4.4.2 Efficacy 45
5.4.4.3 Safety 46
5.4.4.4 Clinical Study Details 46
5.5 DES Market: List of Pipeline Products 47
5.6 Key Takeaway 49
6 Global DES Market : Implications for Future Market Competition 50
6.1 Strategic Competitor Assessment 51
7 Global DES Market: Emerging Companies 52
7.1 Introduction 52
8 Appendix 54
8.1 Definitions 54
8.1.1 Drug Eluting Stents (DES) 54
8.2 Research Methodology 55
8.3 Secondary Research 56
8.4 Primary Research 56
8.5 Models 57
8.6 Forecasts 57
8.7 Expert Panels 57
8.8 GlobalData Consulting 58
8.9 Contact Us 58
8.10 Disclaimer 58